StockData
Curis Inc logo

Curis Inc (CRIS) stock

CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3094% below fair value
$0.44−0.01 (-2.07%)

Close on Nov 16, 2026Market cap $910.86KP/E –Yield –

Curis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Curis's price to sales ratio was 0.3× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 0.3× to 41.4×, with a median of 3.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.8
2025Dec 31, 20251.1×−0.7
2024Dec 31, 20241.8×−5.6
2023Dec 29, 20237.3×+2.3
2022Dec 30, 20225.1×−36.3
2021Dec 31, 202141.4×−0.4
2020Dec 31, 202041.8×+35.8
2019Dec 31, 20196.0×+3.9
2018Dec 31, 20182.1×−10.7
2017Dec 29, 201712.8×−46.7
2016Dec 30, 201659.4×+11.4
2015Dec 31, 201548.0×+34.3
2014Dec 31, 201413.8×−1.9
2013Dec 31, 201315.6×+6.3
2012Dec 31, 20129.3×−453.8
2011Dec 30, 2011463.1×–

More Curis figures

See a number that looks wrong?